Skip to main content
Top
Published in: Gut Pathogens 1/2018

Open Access 01-12-2018 | Letter to the Editor

Identification of Schizosaccharomyces pombe in the guts of healthy individuals and patients with colorectal cancer: preliminary evidence from a gut microbiome secretome study

Authors: Siok-Fong Chin, Putri Intan Hafizah Megat Mohd Azlan, Luqman Mazlan, Hui-min Neoh

Published in: Gut Pathogens | Issue 1/2018

Login to get access

Abstract

Over the years, genetic profiling of the gut microbiome of patients with colorectal cancer (CRC) using genome sequencing has suggested over-representation of several bacterial taxa. However, little is known about the protein or metabolite secretions from the microbiota that could lead to CRC pathology. Proteomic studies on the role of microbial secretome in CRC are relatively rare. Here, we report the identification of proteins from Schizosaccharomyces pombe found in the stool samples of both healthy individuals and patients with CRC. We found that distinctive sets of S. pombe proteins were present exclusively and in high intensities in each group. Our finding may trigger a new interest in the role of gut mycobiota in carcinogenesis.
Literature
1.
go back to reference Dennis G Jr, Sherman BT, Hosack DA, Yang J, Baseler MW, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):3.CrossRef Dennis G Jr, Sherman BT, Hosack DA, Yang J, Baseler MW, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):3.CrossRef
3.
go back to reference Wood V, Gwilliam R, Rajandream M, Lyne M, Lyne R, Stewart A, et al. The genome sequence of Schizosaccharomyces pombe. Nature. 2002;415(6874):871–80.CrossRefPubMed Wood V, Gwilliam R, Rajandream M, Lyne M, Lyne R, Stewart A, et al. The genome sequence of Schizosaccharomyces pombe. Nature. 2002;415(6874):871–80.CrossRefPubMed
4.
go back to reference Gangloff S, Arcangioli B. DNA repair and mutations during quiescence in yeast. FEMS Yeast Res. 2017;17(1):1–14.CrossRef Gangloff S, Arcangioli B. DNA repair and mutations during quiescence in yeast. FEMS Yeast Res. 2017;17(1):1–14.CrossRef
5.
go back to reference Langerak P, Russell P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci. 2011;366(1584):3562–71.CrossRefPubMedPubMedCentral Langerak P, Russell P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci. 2011;366(1584):3562–71.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of Schizosaccharomyces pombe in the guts of healthy individuals and patients with colorectal cancer: preliminary evidence from a gut microbiome secretome study
Authors
Siok-Fong Chin
Putri Intan Hafizah Megat Mohd Azlan
Luqman Mazlan
Hui-min Neoh
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2018
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-018-0258-5

Other articles of this Issue 1/2018

Gut Pathogens 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine